Author Question: Why should an economy specialize and trade according to its marginal cost advantage or comparative ... (Read 44 times)

lilldybug07

  • Hero Member
  • *****
  • Posts: 546
Why should an economy specialize and trade according to its marginal cost advantage or comparative advantage?

Question 2

In economic theory, we assume that the goal of the firm is to:
 a. maximize sales revenue.
  b. maximize market share.
  c. maximize the benefits it provides to its customers.
  d. maximize the profit.
  e. maximize the sales volume.



kswal303

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

Individuals and nations should specialize and trade according to comparative advantage because it ensures an efficient use of resources and benefits both trading partners by allowing them to consume more than what is domestically produced.

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library